NZ720887A - Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptide - Google Patents
Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptideInfo
- Publication number
- NZ720887A NZ720887A NZ720887A NZ72088714A NZ720887A NZ 720887 A NZ720887 A NZ 720887A NZ 720887 A NZ720887 A NZ 720887A NZ 72088714 A NZ72088714 A NZ 72088714A NZ 720887 A NZ720887 A NZ 720887A
- Authority
- NZ
- New Zealand
- Prior art keywords
- crystalline forms
- hcv
- macrocyclic hcv
- tripeptide
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361920427P | 2013-12-23 | 2013-12-23 | |
| PCT/US2014/071310 WO2015100144A1 (en) | 2013-12-23 | 2014-12-18 | Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ720887A true NZ720887A (en) | 2018-01-26 |
Family
ID=52282995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ720887A NZ720887A (en) | 2013-12-23 | 2014-12-18 | Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptide |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9562058B2 (OSRAM) |
| EP (1) | EP3087086B1 (OSRAM) |
| JP (2) | JP6568541B2 (OSRAM) |
| AR (1) | AR098958A1 (OSRAM) |
| AU (1) | AU2014370124A1 (OSRAM) |
| CA (1) | CA2934049A1 (OSRAM) |
| ES (1) | ES2708993T3 (OSRAM) |
| NZ (1) | NZ720887A (OSRAM) |
| PT (1) | PT3087086T (OSRAM) |
| TW (1) | TW201609752A (OSRAM) |
| UY (1) | UY35918A (OSRAM) |
| WO (1) | WO2015100144A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014370125B2 (en) | 2013-12-23 | 2017-11-16 | Gilead Sciences, Inc. | Synthesis of a macrocyclic HCV NS3 inhibiting tripeptide |
| SG11201705069YA (en) | 2014-12-26 | 2017-07-28 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| BR102017011025A2 (pt) * | 2016-06-02 | 2017-12-19 | Gilead Pharmasset Llc | Formulation of combination of three antiviral compounds |
| PL3706762T3 (pl) | 2017-12-07 | 2025-02-10 | Emory University | N4-hydroksycytydyna i pochodne oraz związane z nimi zastosowania przeciwwirusowe |
| CN115417803B (zh) * | 2022-08-30 | 2023-10-03 | 四川同晟生物医药有限公司 | 乌帕替尼中间体(3r,4s)-1-苄氧羰基-4-乙基吡咯烷-3-羧酸的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| CL2008003384A1 (es) * | 2007-11-14 | 2009-12-11 | Enanta Pharm Inc | Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c. |
| EP2540349B1 (en) * | 2008-07-22 | 2014-02-12 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions comprising a macrocyclic quinoxaline compound which is an hcv ns3 protease inhibitor |
| SG188618A1 (en) * | 2010-09-21 | 2013-04-30 | Enanta Pharm Inc | Macrocyclic proline derived hcv serine protease inhibitors |
| WO2012040040A1 (en) * | 2010-09-21 | 2012-03-29 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
| PL2635588T3 (pl) | 2011-11-16 | 2015-10-30 | Gilead Pharmasset Llc | Skondensowane imidazoliloimidazole jako związki antywirusowe |
| UA119315C2 (uk) * | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
-
2014
- 2014-12-18 ES ES14824322T patent/ES2708993T3/es active Active
- 2014-12-18 PT PT14824322T patent/PT3087086T/pt unknown
- 2014-12-18 JP JP2016560857A patent/JP6568541B2/ja not_active Expired - Fee Related
- 2014-12-18 NZ NZ720887A patent/NZ720887A/en not_active IP Right Cessation
- 2014-12-18 AU AU2014370124A patent/AU2014370124A1/en not_active Abandoned
- 2014-12-18 WO PCT/US2014/071310 patent/WO2015100144A1/en not_active Ceased
- 2014-12-18 EP EP14824322.3A patent/EP3087086B1/en active Active
- 2014-12-18 US US14/575,966 patent/US9562058B2/en active Active
- 2014-12-18 CA CA2934049A patent/CA2934049A1/en not_active Abandoned
- 2014-12-22 TW TW103144805A patent/TW201609752A/zh unknown
- 2014-12-23 UY UY0001035918A patent/UY35918A/es not_active Application Discontinuation
- 2014-12-23 AR ARP140104909A patent/AR098958A1/es unknown
-
2016
- 2016-12-21 US US15/387,318 patent/US9862728B2/en active Active
-
2019
- 2019-02-07 JP JP2019020540A patent/JP2019089819A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2934049A1 (en) | 2015-07-02 |
| UY35918A (es) | 2015-05-29 |
| EP3087086B1 (en) | 2018-11-07 |
| ES2708993T3 (es) | 2019-04-12 |
| JP6568541B2 (ja) | 2019-08-28 |
| JP2019089819A (ja) | 2019-06-13 |
| US9562058B2 (en) | 2017-02-07 |
| JP2017503016A (ja) | 2017-01-26 |
| US9862728B2 (en) | 2018-01-09 |
| AR098958A1 (es) | 2016-06-22 |
| PT3087086T (pt) | 2019-02-06 |
| EP3087086A1 (en) | 2016-11-02 |
| US20170267694A1 (en) | 2017-09-21 |
| US20150175625A1 (en) | 2015-06-25 |
| TW201609752A (zh) | 2016-03-16 |
| WO2015100144A1 (en) | 2015-07-02 |
| AU2014370124A1 (en) | 2016-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ720887A (en) | Crystalline forms of a macrocyclic hcv ns3 inhibiting tripeptide | |
| WO2013059530A3 (en) | Peptidomimetic macrocycles | |
| EP3040193A4 (en) | Waterproof breathable membrane, waterproof breathable component provided with same, waterproof breathable structure, and waterproof sound-permeable membrane | |
| HK1205454A1 (en) | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles | |
| WO2014152969A3 (en) | Systems and methods for a secure carabineer key ring | |
| MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
| HK1202549A1 (en) | Donepezil pamoate, preparation method and its use | |
| MX2014003180A (es) | Metodos para tratar vhc. | |
| WO2018098282A3 (en) | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof | |
| MX362489B (es) | Inhibidores dipeptídicos y tripeptídicos de epoxi cetona proteasa. | |
| EP2112907A4 (en) | PEARL FOR SEWING, VACUUM CAP FOR SUCKING AN INNER ORGAN AND DEVICE FOR SEWING AN INNER ORGAN | |
| WO2015058132A3 (en) | Anti-rsp02 and/or anti-rsp03 antibodies and their uses | |
| NZ629130A (en) | Tfpi inhibitors and methods of use | |
| MY160372A (en) | Composition for improving brain function and method for improving brain function | |
| USD712560S1 (en) | Solarium equipment | |
| CA3011003A1 (en) | Bacterial ghosts for the treatment of cancer | |
| WO2014145314A3 (en) | Methods and compositions for gamma-glutamyl cycle modulation | |
| WO2016007956A3 (en) | Cyclic tetrapeptide stereoisomers | |
| EP2039708A4 (en) | CYCLOOLEFIN ADDITIVE COPOLYMER, PREPARATION METHOD AND COPOLYMER RECEIVED DELAYING FILM | |
| HK1224304A1 (zh) | 用於治療嚴重低血糖的新穎的化合物 | |
| WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
| HK1206977A1 (en) | Aromatic-cationic peptides and uses of same | |
| WO2012139074A3 (en) | Migrastatins and uses thereof | |
| USD754417S1 (en) | Necktie device | |
| EP3274478A4 (en) | Hcv ns4a/modified ns3 polypeptides and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |